Diagnostic performance of serum IgG4 levels in patients with IgG4-related disease

Medicine (United States)

Volumn 94, Issue 41, 2015, Pages

  Yu, Kuang Hui ^a,b,c   Chan, Tien Ming ^a,b   Tsai, Ping Han ^a,b   Cheng, Ching Hui ^b   Chang, Pi Yueh ^b,c  

^a Division of Rheumatology   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G4; BIOLOGICAL MARKER; IMMUNOGLOBULIN G;

ADULT; AGED; AORTITIS; AREA UNDER THE CURVE; ARTICLE; AUTOIMMUNE PANCREATITIS; CHINESE; CONTROLLED STUDY; DACRYOCYSTITIS; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN G4 RELATED DISEASE; LUNG DISEASE; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MIKULICZ DISEASE; ORBIT PSEUDOTUMOR; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROPERITONEAL FIBROSIS; SCLEROSING CHOLANGITIS; SENSITIVITY AND SPECIFICITY; SIALOADENITIS; SINUS HISTIOCYTOSIS; SKIN DISEASE; SPLEEN DISEASE; AUTOIMMUNE DISEASES; BLOOD; MIDDLE AGED; TAIWAN; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AUTOIMMUNE DISEASES; BIOMARKERS; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TAIWAN;

EID: 84944451693     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000001707     Document Type: Article

References (48)

1. Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366:539-551.
2. Kamisawa T, Zen Y, Pillai S, et al. IgG4-related disease. Lancet. 2015;385:1460-1471.
3. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732-738.
4. Stone JH, Khosroshahi A, Deshpande V, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 2012;64: 3061-3067.
5. Ryu JH, Horie R, Sekiguchi H, et al. Spectrum of disorders associated with elevated serum IgG4 levels encountered in clinical practice. Int J Rheumatol. 2012;2012:232960.
6. Islam AD, Selmi C, Datta-Mitra A, et al. The changing faces of IgG4-related disease: clinical manifestations and pathogenesis. Auto-immun Rev. 2015;14:914-922.
7. Brito-Zerón P, Ramos-Casals M, Bosch X, et al. The clinical spectrum of IgG4-related disease. Autoimmun Rev. 2014;13: 1203-1210.
8. Chari ST, Smyrk TC, Levy MJ, et al. Diagnosis of autoimmune pancreatitis: The Mayo Clinic experience. Clin Gastroenterol Hepa-tol. 2006;4:1010-1016.
9. Ghazale A, Chari ST, Smyrk TC, et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol. 2007;102: 1646-1653.
10. Ryu JK, Chung JB, Park SW, et al. Review of 67 patients with autoimmune pancreatitis in Korea: a multicenter nationwide study. Pancreas. 2008;37:377-385.
11. Morselli-Labate AM, Pezzilli R. Usefulness of serum IgG4 in the diagnosis and follow up of autoimmune pancreatitis: a systematic literature review and meta-analysis. J Gastroenterol Hepatol. 2009;24:15-36.
12. Xin L, He YX, Zhu XF, et al. Diagnosis and treatment of autoimmune pancreatitis: experience with 100 patients. Hepatobiliary Pancreat Dis Int. 2014;13:642-648.
13. Ngwa TN, Law R, Murray D, et al. Serum immunoglobulin G4 level is a poor predictor of immunoglobulin G4-related disease. Pancreas. 2014;43:704-707.
14. Yun J, Wienholt L, Adelstein S. Poor positive predictive value of serum immunoglobulin G4 concentrations in the diagnosis of immunoglobulin G4-related sclerosing disease. Asia Pac Allergy. 2014;4:172-176.
15. Masaki Y, Kurose N, Yamamoto M, et al. Cutoff values of serum IgG4 and histopathological IgG4 plasma cells for diagnosis of patients with IgG4-related disease. Int J Rheumatol. 2012;2012:580814.
16. Tabata T, Kamisawa T, Takuma K, et al. Serum IgG4 concentrations and IgG4-related sclerosing disease. Clin Chim Acta. 2009;408: 25-28.
17. Kamisawa T, Takuma K, Tabata T, et al. Serum IgG4-negative autoimmune pancreatitis. J Gastroenterol. 2011;46:108-116.
18. Sadler R, Chapman RW, Simpson D, et al. The diagnostic significance of serum IgG4 levels in patients with autoimmune pancreatitis: a UK study. Eur J Gastroenterol Hepatol. 2011;23: 139-145.
19. Carruthers MN, Khosroshahi A, Augustin T, et al. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis. 2015;74:14-18.
20. Aparisi L, Farre A, Gomez-Cambronero L, et al. Antibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: relevance for diagnosis of autoimmune pancreatitis. Gut. 2005;54:703-709.
21. Song TJ, Kim MH, Moon SH, et al. The combined measurement of total serum IgG and IgG4 may increase diagnostic sensitivity for autoimmune pancreatitis without sacrificing specificity, compared with IgG4 alone. Am J Gastroenterol. 2010;105:1655-1660.
22. Zen Y, Nakanuma Y. IgG4-related disease: a cross-sectional study of 114 cases. Am J Surg Pathol. 2010;34:1812-1819.
23. Patel H, Khalili K, Kyoung KT, et al. IgG4 related disease - A retrospective descriptive study highlighting Canadian experiences in diagnosis and management. BMC Gastroenterol. 2013;13:168.
24. Choi EK, Kim MH, Lee TY, et al. The sensitivity and specificity of serum immunoglobulin G and immunoglobulin G4 levels in the diagnosis of autoimmune chronic pancreatitis: Korean experience. Pancreas. 2007;35:156-161.
25. Raina A, Yadav D, Krasinskas AM, et al. Evaluation and management of autoimmune pancreatitis: experience at a large US center. Am J Gastroenterol. 2009;104:2295-2306.
26. Song Y, Liu Q-D, Zhou N-X, et al. Diagnosis and management of autoimmune pancreatitis: experience from China. World J Gastro-enterol. 2008;14:601-606.
27. Lin L-F, Huang P-T, Ho K-S, et al. Autoimmune chronic pancreatitis. J Chin Med Assoc. 2008;71:14-22.
28. Kamisawa T, Kim MH, Liao WC, et al. Clinical characteristics of 327 Asian patients with autoimmune pancreatitis based on Asian diagnostic criteria. Pancreas. 2011;40:200-205.
29. Yamamoto M, Tabeya T, Naishiro Y, et al. Value of serum IgG4 in the diagnosis of IgG4-related disease and in differentiation from rheumatic diseases and other diseases. Mod Rheumatol. 2012;22:419-425.
30. Yamamoto M, Takahashi H, Ohara M, et al. A new conceptualization for Mikulicz's disease as an IgG4-related plasmacytic disease. Mod Rheumatol. 2006;16:335-340.
31. Khosroshahi A, Cheryk LA, Carruthers MN, et al. Spuriously low serum IgG4 concentrations caused by the prozone phenomenon in patients with IgG4-related disease. Arthritis Rheumatol. 2014;66:213-217.
32. Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22:21-30.
33. Nishimori I, Otsuki M. Autoimmune pancreatitis and IgG4-asso-ciated sclerosing cholangitis. Best Pract Res Clin Gastroenterol. 2009;23:11-23.
34. Nishimori I, Onishi S, Otsuki M. Nationwide survey for autoimmune pancreatitis in Japan. J Jpn Panc Soc. 2007;22:651-656.
35. Frulloni L, Scattolini C, Falconi M, et al. Autoimmune pancreatitis: differences between the focal and diffuse forms in 87 patients. Am J Gastroenterol. 2009;104:2288-2294.
36. Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol. 2003;38:982-984.
37. Kamisawa T. IgG4-positive plasma cells specifically infiltrate various organs in autoimmune pancreatitis. Pancreas. 2004;29: 167-168.
38. Raina A, Krasinskas AM, Greer JB, et al. Serum immunoglobulin G fraction 4 levels in pancreatic cancer: elevations not associated with autoimmune pancreatitis. Arch Pathol Lab Med. 2008;132: 48-53.
39. Kanno A, Nishimori I, Masamune A, et al. Nationwide epidemiolo-gical survey of autoimmune pancreatitis in Japan. Pancreas. 2012;41:835-839.
40. Fujita A, Sakai O, Chapman MN, et al. IgG4-related disease of the head and neck: CT and MR imaging manifestations. Radiographics. 2012;32:1945-1958.
41. Hirano K, Kawabe T, Yamamoto N, et al. Serum IgG4 concentrations in pancreatic and biliary diseases. Clin Chim Acta. 2006;367:181-184.
42. Yamamoto M, Ohara M, Suzuki C, et al. Elevated IgG4 concentrations in serum of patients with Mikulicz's disease. Scand J Rheumatol. 2004;33:432-433.
43. Chari ST, Takahashi N, Levy MJ, et al. A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. Clin Gastroenterol Hepatol. 2009;7:1097-1103.
44. Shimosegawa T. The Amendment of the Clinical Diagnostic Criteria in Japan (JPS2011) in Response to the Proposal of the International Consensus of Diagnostic Criteria (ICDC) for Autoimmune Pancreatitis. Pancreas. 2012;41:1341-1342.
45. Okazaki K, Kawa S, Kamisawa T, et al. Japanese clinical guidelines for autoimmune pancreatitis. Pancreas. 2009;38:849-866.
46. Ohara H, Okazaki K, Tsubouchi H, et al. Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012. J Hepatobiliary Pan-creat Sci. 2012;19:536-542.
47. Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 2011;40:352-358.
48. Beyer G, Schwaiger T, Lerch MM, et al. IgG4-related disease: a new kid on the block or an old aquaintance? United Eur Gastroenterol J. 2014;2:165-172.